Bo Chen

Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial

Shu-Lian Wang, Hui Fang, Yong-Wen Song et al. · The Lancet Oncology · 2019 · 387 citations

Surgical Oncology, High-risk Breast Cancer, Breast Oncology +8

Genomic Profiling of MicroRNAs and Messenger RNAs Reveals Hormonal Regulation in MicroRNA Expression in Human Endometrium1

Satu Kuokkanen, Bo Chen, Laureen S. Ojalvo et al. · Biology of Reproduction · 2009 · 288 citations · Full text

Gynecology, Menstrual Cycle, Epigenetics +22

High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer

Xiaojia Huang, Xing Li, Xinhua Xie et al. · The Breast · 2016 · 143 citations · Full text

Genetic and epigenetic silencing of the beclin 1gene in sporadic breast tumors

Zidong Li, Bo Chen, Yiqing Wu et al. · BMC Cancer · 2010 · 132 citations · Full text

miR-185 Suppresses Tumor Proliferation by Directly Targeting E2F6 and DNMT1 and Indirectly Upregulating BRCA1 in Triple-Negative Breast Cancer

Hailin Tang, Peng Liu, Lu Yang et al. · Molecular Cancer Therapeutics · 2014 · 108 citations · Full text

Indirectly Upregulating Brca1, Breast Oncology, Medicine +14